Trial of LHRHa, abiraterone and enzalutamide: filling an unmet need in prostate cancer therapy
Eleni Efstathiou, MD, PhD of the University of Texas MD Anderson Cancer Center, Houston, Texas, TX, provides an overview of the Phase II trial of leuprolide acetate (LHRHa) and abiraterone acetate wit...
Author: VJOncology
Added: 08/25/2016
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
More News: Abiraterone Acetate | Cancer | Cancer & Oncology | Cancer Therapy | Prostate Cancer | Texas University